Inhibition of neutrophil elastase reduces lung injury and bacterial count in hamsters

Tetsuya Hagio, Katsuya Kishikawa, Kazuhito Kawabata, Sadatomo Tasaka, Satoru Hashimoto, Naoki Hasegawa, Akitoshi Ishizaka

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Neutrophil elastase (NE) has been recognized as a double-edge sword as it can be both host-defensive and pro-inflammatory depending on its tissue level and microenvironment. The present study was designed to examine whether inhibition of NE activity by sivelestat, a specific NE inhibitor with low cellular permeability, is beneficial for acute lung injury induced by Streptococcus pneumoniae in hamsters. Intratracheal inoculation of live S. pneumoniae (1.5×107 CFU/Lung) into hamsters caused acute lung injury characterized by an increase in lung alveolar permeability and leukocytes accumulation in the lungs. These pathophysiological changes, which were associated with elevation of NE activity in the bronchoalveolar lavage fluid (BALF), were transient but remained high 4-22 h post-bacterial inoculation. Intravenous infusion of sivelestat at 3 mg/kg/h 0-22 h after bacterial inoculation reduced the increase in NE activity and lung alveolar permeability, as indicated by leakage of pre-injected human serum albumin into BALF, without affecting the number of leukocytes in BALF and lung interstitial tissue. Interestingly, the number of bacteria in BALF and lung interstitial tissue was also reduced by sivelestat to less than 10% of the control values. Furthermore, S. pneumoniae-induced decrease in the level of surfactant protein D (SP-D), a protein that protects against bacterial infection, was preserved by sivelestat treatment with a significant negative correlation between NE activity and SP-D content in BALF. These results suggest that sivelestat is beneficial in acute lung injury associated with lung bacterial infection and that this inhibitor rather decreases infection by preserving host defense system.

Original languageEnglish
Pages (from-to)884-891
Number of pages8
JournalPulmonary Pharmacology and Therapeutics
Volume21
Issue number6
DOIs
Publication statusPublished - 2008 Dec

Fingerprint

Leukocyte Elastase
Bacterial Load
Lung Injury
Cricetinae
Bronchoalveolar Lavage Fluid
Lung
Fluids
Pulmonary Surfactant-Associated Protein D
Acute Lung Injury
Streptococcus pneumoniae
Tissue
Permeability
Secretory Proteinase Inhibitory Proteins
Bacterial Infections
Leakage (fluid)
Serum Albumin
Bacteria
sivelestat
Leukocyte Count
Intravenous Infusions

Keywords

  • Acute lung injury
  • Bacterial infection
  • Protease inhibitor
  • Sivelestat
  • Surfactant protein D

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Pharmacology (medical)
  • Biochemistry, medical

Cite this

Inhibition of neutrophil elastase reduces lung injury and bacterial count in hamsters. / Hagio, Tetsuya; Kishikawa, Katsuya; Kawabata, Kazuhito; Tasaka, Sadatomo; Hashimoto, Satoru; Hasegawa, Naoki; Ishizaka, Akitoshi.

In: Pulmonary Pharmacology and Therapeutics, Vol. 21, No. 6, 12.2008, p. 884-891.

Research output: Contribution to journalArticle

Hagio, Tetsuya ; Kishikawa, Katsuya ; Kawabata, Kazuhito ; Tasaka, Sadatomo ; Hashimoto, Satoru ; Hasegawa, Naoki ; Ishizaka, Akitoshi. / Inhibition of neutrophil elastase reduces lung injury and bacterial count in hamsters. In: Pulmonary Pharmacology and Therapeutics. 2008 ; Vol. 21, No. 6. pp. 884-891.
@article{f6c3a7ca100e458388887629c0e9186b,
title = "Inhibition of neutrophil elastase reduces lung injury and bacterial count in hamsters",
abstract = "Neutrophil elastase (NE) has been recognized as a double-edge sword as it can be both host-defensive and pro-inflammatory depending on its tissue level and microenvironment. The present study was designed to examine whether inhibition of NE activity by sivelestat, a specific NE inhibitor with low cellular permeability, is beneficial for acute lung injury induced by Streptococcus pneumoniae in hamsters. Intratracheal inoculation of live S. pneumoniae (1.5×107 CFU/Lung) into hamsters caused acute lung injury characterized by an increase in lung alveolar permeability and leukocytes accumulation in the lungs. These pathophysiological changes, which were associated with elevation of NE activity in the bronchoalveolar lavage fluid (BALF), were transient but remained high 4-22 h post-bacterial inoculation. Intravenous infusion of sivelestat at 3 mg/kg/h 0-22 h after bacterial inoculation reduced the increase in NE activity and lung alveolar permeability, as indicated by leakage of pre-injected human serum albumin into BALF, without affecting the number of leukocytes in BALF and lung interstitial tissue. Interestingly, the number of bacteria in BALF and lung interstitial tissue was also reduced by sivelestat to less than 10{\%} of the control values. Furthermore, S. pneumoniae-induced decrease in the level of surfactant protein D (SP-D), a protein that protects against bacterial infection, was preserved by sivelestat treatment with a significant negative correlation between NE activity and SP-D content in BALF. These results suggest that sivelestat is beneficial in acute lung injury associated with lung bacterial infection and that this inhibitor rather decreases infection by preserving host defense system.",
keywords = "Acute lung injury, Bacterial infection, Protease inhibitor, Sivelestat, Surfactant protein D",
author = "Tetsuya Hagio and Katsuya Kishikawa and Kazuhito Kawabata and Sadatomo Tasaka and Satoru Hashimoto and Naoki Hasegawa and Akitoshi Ishizaka",
year = "2008",
month = "12",
doi = "10.1016/j.pupt.2008.10.002",
language = "English",
volume = "21",
pages = "884--891",
journal = "Pulmonary Pharmacology and Therapeutics",
issn = "1094-5539",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Inhibition of neutrophil elastase reduces lung injury and bacterial count in hamsters

AU - Hagio, Tetsuya

AU - Kishikawa, Katsuya

AU - Kawabata, Kazuhito

AU - Tasaka, Sadatomo

AU - Hashimoto, Satoru

AU - Hasegawa, Naoki

AU - Ishizaka, Akitoshi

PY - 2008/12

Y1 - 2008/12

N2 - Neutrophil elastase (NE) has been recognized as a double-edge sword as it can be both host-defensive and pro-inflammatory depending on its tissue level and microenvironment. The present study was designed to examine whether inhibition of NE activity by sivelestat, a specific NE inhibitor with low cellular permeability, is beneficial for acute lung injury induced by Streptococcus pneumoniae in hamsters. Intratracheal inoculation of live S. pneumoniae (1.5×107 CFU/Lung) into hamsters caused acute lung injury characterized by an increase in lung alveolar permeability and leukocytes accumulation in the lungs. These pathophysiological changes, which were associated with elevation of NE activity in the bronchoalveolar lavage fluid (BALF), were transient but remained high 4-22 h post-bacterial inoculation. Intravenous infusion of sivelestat at 3 mg/kg/h 0-22 h after bacterial inoculation reduced the increase in NE activity and lung alveolar permeability, as indicated by leakage of pre-injected human serum albumin into BALF, without affecting the number of leukocytes in BALF and lung interstitial tissue. Interestingly, the number of bacteria in BALF and lung interstitial tissue was also reduced by sivelestat to less than 10% of the control values. Furthermore, S. pneumoniae-induced decrease in the level of surfactant protein D (SP-D), a protein that protects against bacterial infection, was preserved by sivelestat treatment with a significant negative correlation between NE activity and SP-D content in BALF. These results suggest that sivelestat is beneficial in acute lung injury associated with lung bacterial infection and that this inhibitor rather decreases infection by preserving host defense system.

AB - Neutrophil elastase (NE) has been recognized as a double-edge sword as it can be both host-defensive and pro-inflammatory depending on its tissue level and microenvironment. The present study was designed to examine whether inhibition of NE activity by sivelestat, a specific NE inhibitor with low cellular permeability, is beneficial for acute lung injury induced by Streptococcus pneumoniae in hamsters. Intratracheal inoculation of live S. pneumoniae (1.5×107 CFU/Lung) into hamsters caused acute lung injury characterized by an increase in lung alveolar permeability and leukocytes accumulation in the lungs. These pathophysiological changes, which were associated with elevation of NE activity in the bronchoalveolar lavage fluid (BALF), were transient but remained high 4-22 h post-bacterial inoculation. Intravenous infusion of sivelestat at 3 mg/kg/h 0-22 h after bacterial inoculation reduced the increase in NE activity and lung alveolar permeability, as indicated by leakage of pre-injected human serum albumin into BALF, without affecting the number of leukocytes in BALF and lung interstitial tissue. Interestingly, the number of bacteria in BALF and lung interstitial tissue was also reduced by sivelestat to less than 10% of the control values. Furthermore, S. pneumoniae-induced decrease in the level of surfactant protein D (SP-D), a protein that protects against bacterial infection, was preserved by sivelestat treatment with a significant negative correlation between NE activity and SP-D content in BALF. These results suggest that sivelestat is beneficial in acute lung injury associated with lung bacterial infection and that this inhibitor rather decreases infection by preserving host defense system.

KW - Acute lung injury

KW - Bacterial infection

KW - Protease inhibitor

KW - Sivelestat

KW - Surfactant protein D

UR - http://www.scopus.com/inward/record.url?scp=56949084283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56949084283&partnerID=8YFLogxK

U2 - 10.1016/j.pupt.2008.10.002

DO - 10.1016/j.pupt.2008.10.002

M3 - Article

C2 - 18992355

AN - SCOPUS:56949084283

VL - 21

SP - 884

EP - 891

JO - Pulmonary Pharmacology and Therapeutics

JF - Pulmonary Pharmacology and Therapeutics

SN - 1094-5539

IS - 6

ER -